Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol.
- Resource Type
- Article
- Source
- BMJ Open; Jun2017, Vol. 7 Issue 6, p1-8, 8p, 2 Diagrams
- Subject
- Language
- ISSN
- 20446055